Reflection Asset Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.89M Buy
1,630
+223
+16% +$263K 0.78% 33
2026
Q2
$1.69M Sell
1,407
-69
-5% -$70.5K 0.79% 30
2026
Q1
$1.36M Buy
1,476
+441
+43% +$447K 0.83% 35
2025
Q4
$1.11M Buy
+1,035
New +$990K 0.79% 38

Other funds holding LLY

Reflection Asset Management's LLY Position: Q3 2026 in Review

Reflection Asset Management increased its Eli Lilly (LLY) stake by 16% in Q3 2026, buying an estimated $263K and bringing the position to 1,630 shares worth $1.89M. The position accounts for 0.78% of the portfolio, ranked #33.

Reflection Asset Management first reported a position in LLY in Q4 2025 and has held it in 4 quarters since. 4,616 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • Reflection Asset Management held 1,630 shares of Eli Lilly worth $1.89M as of Q3 2026.
  • Reflection Asset Management bought 223 Eli Lilly shares in Q3 2026, an estimated $263K.
  • Eli Lilly made up 0.78% of Reflection Asset Management's portfolio in Q3 2026, its #33 holding.
  • Reflection Asset Management first reported a position in Eli Lilly in Q4 2025 and has held it in 4 quarters since.
  • 4,616 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on Reflection Asset Management's 13F filing for Q3 2026, filed 28 Oct 2026.